-+ 0.00%
-+ 0.00%
-+ 0.00%

IPO News | Bonasia Port IPO Prospectus Expires

Zhitongcaijing·08/10/2026 22:25:05
Listen to the news

The Zhitong Finance App learned that the Hong Kong stock prospectus submitted by Bonasia (Hangzhou) Pharmaceutical Technology Co., Ltd. (abbreviation: Bonasia) on February 11, 2026 expired on August 11, 2026, and submitted Shixing Securities International and ICBC International as co-sponsors.

587cf0d7-052e-4227-ab1c-d761c5601cb7.png

According to a previous prospectus, Bonasia is a clinical contract research organization (“CRO”) organization headquartered in Hangzhou, China, dedicated to empowering clinical research on innovative drugs through digitalization. The company's core business is to provide clinical trial technical services to domestic and foreign pharmaceutical and biotechnology companies, with the aim of accelerating the development and commercialization of chemical drugs and biological products.